Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
| Brand name | TEMOZOLOMIDE |
| Generic name | TEMOZOLOMIDE |
| Active ingredient(s) | TEMOZOLOMIDE |
| Distributed by / for | Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan |
| NDC | 16571-816-51 |
| Full product label | Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. |
| Recalling firm | Rising Pharma Holding, Inc. |
| Distribution | Nationwide within the U.S |
| Quantity | 1200 bottles |
| Recall initiated | 2026-03-03 |
| Report date | 2026-03-11 |
| Recall completed | — |
| Recall number | D-0384-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗